Table 5 Normalized miRNA expression (2^(−Avg.(Delta(Ct)) in Group 2 (CML patients non-responsive to imatinib therapy) and Control Group (blood donors) of significant miRNAs calculated by Gene Globe Data Analysis Centre (QIAGEN)
|  | Average Ct | Average Delta(Ct) (Ct(miROI) - Average Ct(normalisation factor)) | 2^(−Average(Delta(Ct)) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mature ID | Control Group | Standard Deviation | Group 2 | Standard Deviation | Control Group | Standard Deviation | Group 2 | Standard Deviation | Control Group | Group 2 |
hsa-miR-181a-5p | 24.99 | 0.804605 | 26.01 | 1.340582 | 5.146885 | 0.734814 | 6.366369 | 0.836165 | 0.028225 | 0.012121 |
hsa-miR-182-5p | 23.46 | 0.811293 | 22.21 | 1.120019 | 3.621528 | 0.636088 | 2.563155 | 0.647466 | 0.081248 | 0.169205 |
hsa-miR-26a-5p | 21.11 | 0.829467 | 19.65 | 1.452098 | 1.264028 | 0.409326 | 0.005655 | 0.833271 | 0.416380 | 0.996088 |